Table 5.

The Evaluation of Adnex Model without ca125 to Predict Risk of Malignancy in Ovarian Mass

Cut-off	Se (%) (95% CI)	Sp (%) (95% CI)	PPV (%) (95% CI)	NPV (%) (95% CI)
3%	96.9 (89.3 – 99.6)	33.3 (28.7 – 38.2)	19.3 (18.0 – 20.6)	98.5 (94.4 – 99.6)
5%	96.9 (89.3 – 99.6)	72.7 (68.1 – 77.1)	36.8 (33.1 – 40.8)	99.3 (97.4 – 99.8)
10%	93.9 (85.0 – 98.3)	90.2 (86.8 – 92.9)	61 (53.6 – 68.0)	98.9 (97.2 – 99.6)
15.30%	90.8 (81.0 – 96.5)	92.7 (89.7- 95.0)	67 (58.7 – 74.4)	98.4 (96.6 – 99.2)
21%	87.7 (77.2 – 94.5)	94.2 (91.4 – 96.3)	71.3 (62.3 – 78.8)	97.9 (96.1 – 98.9)
30.60%	83.1 (71.7 – 91.2)	96.5 (94.1 – 98.1)	79.4 (69.5 – 86.7)	97.2 (95.3 – 98.3)
50%	69.2 (56.6 – 80.1)	98.2 (96.4 – 99.3)	86.5 (75.2 – 93.2)	95.1 (93.1 – 96.6)